20 LATEST RESOURCES (225 INDEXED)
Cariprazine in Offender Patient with Acute Psychosis and Aggressive Behavior: Case Report · December 2022
Articles
Psychiatry Research Case Reports
Guanfacine for Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and/or Oppositional Defiance Disorder · July 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
OROS-Methylphenidate to Reduce ADHD Symptoms in Male Prisoners Aged 16-25 Years: A RCT · July 2022
Publications (Books-Reports)
National Institute for Health and Care Research
Randomised Controlled Trial of the Short-Term Effects of Osmotic-Release Oral System Methylphenidate on Symptoms and Behavioural Outcomes in Young Male Prisoners with Attention Deficit Hyperactivity Disorder: CIAO-II Study · June 2022
Articles
British Journal of Psychiatry
Guanfacine for Irritability, Impulsivity, and Agitation in Elderly Patients: A Report of Two Cases · May 2022
Articles
Psychiatry and Clinical Neurosciences Reports
Can Pediatric Bipolar Disorder Be Successfully Treated When Comorbid with Conduct Disorder? A Secondary Analysis of Clinical Trials of Risperidone, Olanzapine, Quetiapine, Ziprasidone, and Aripiprazole · May 2022
Abstracts
Journal of Psychopharmacology
A Pilot Implementation Study to Scale-Up Methadone in Incarcerated Persons with Opioid Use Disorder and Retain Them on Treatment After Release in Moldova · April 2022
Articles (Manuscripts-Versions)
PubMed Central>International Journal on Drug Policy
Perceptions and Experiences Toward Extended-Release Buprenorphine among Persons Leaving Jail with Opioid Use Disorders Before and During COVID-19: An In-Depth Qualitative Study · January 2022
Articles
Addiction Science and Clinical Practice
Psilocybin Use Is Associated with Lowered Odds of Crime Arrests in US Adults: A Replication and Extension · January 2022
Abstracts
Journal of Psychopharmacology
Buprenorphine Induction in a Rural Maryland Detention Center during COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals with Opioid Use Disorder · October 2021
Articles
Frontiers in Psychiatry
Neural Responses to Fluoxetine in Youths with Disruptive Behavior and Trauma Exposure: A Pilot Study · October 2021
Articles
Journal of Child and Adolescent Psychopharmacology
Comparison of Treatment Retention of Adults with Opioid Addiction Managed with Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release from Jail · September 2021
Articles
JAMA Network Open
Transition from Methadone to Subcutaneous Buprenorphine Depot in Patients with Opioid Use Disorder in Custodial Setting: A Case Series · August 2021
Articles
American Journal of Drug and Alcohol Abuse
Retrospective Observational Study of Daytime Add-On Administration of Zopiclone to Difficult-to-Treat Psychiatric Inpatients with Unpredictable Aggressive Behavior, with or without EEG Dysrhythmia · August 2021
Articles
Frontiers in Psychiatry
Duchenne Muscular Dystrophy Successfully Treated with Aripiprazole in a Patient with Autism Spectrum Disorder Symptoms Including Irritability · June 2021
Articles
Internal Medicine
Effect of Methylphenidate on Resting-State Connectivity in Adolescents with a Disruptive Behavior Disorder: A Double-Blind Randomized Placebo-Controlled fMRI Study · June 2021
Articles
Frontiers in Psychiatry
Aripiprazole in the Real-World Treatment for Irritability Associated with Autism Spectrum Disorder in Children and Adolescents in Japan: 52-Week Post-Marketing Surveillance · April 2021
Articles
BMC Psychiatry
Long-Acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-Involved Adults (EXIT-CJS) · April 2021
Articles (Manuscripts-Versions)
PubMed Central>Journal of Substance Abuse Treatment
Extended Release Injectable Naltrexone Before vs. After Release: A Randomized Trial of Opioid Addicted Persons Who Are in Prison · March 2021
Abstracts
Journal of Substance Abuse Treatment